Laurence Picon

Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped

Édouard Louis, Jean‐Yves Mary, Gwénola Vernier-Massouille et al. · Gastroenterology · 2011 · 593 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +14

Infliximab Plus Azathioprine for Steroid-Dependent Crohn’s Disease Patients: A Randomized Placebo-Controlled Trial

Marc Lémann, Jean–Yves Mary, Bernard Duclos et al. · Gastroenterology · 2006 · 372 citations

Pharmacy, Immunology, Pharmacotherapy +12

Efficacy of adalimumab in patients with Crohn's disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) study

Yoram Bouhnik, Franck Carbonnel, David Laharie et al. · Gut · 2017 · 333 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +14

Alterations in the Intestinal Microbiome (Dysbiosis) as a Predictor of Relapse After Infliximab Withdrawal in Crohnʼs Disease

Sylvie Rajca, Virginie Grondin, Édouard Louis et al. · Inflammatory Bowel Diseases · 2014 · 236 citations · Full text

Life Sciences, Immunology, Microbiology +17

Infliximab Pharmacokinetics in Inflammatory Bowel Disease Patients

David Ternant, Alexandre Aubourg, Charlotte Magdelaine–Beuzelin et al. · Therapeutic Drug Monitoring · 2008 · 181 citations

Pharmacy, Pharmacokinetics, Pharmacology +17